UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effect of clopidogrel on thrombin generation in platelet-rich plasma in the rat

Thrombosis and haemostasis, 1999-06, Vol.81 (6), p.957-960

1999

Volltextzugriff (PDF)

Soluble HLA-G1 inhibits angiogenesis through an apoptotic pathway and by direct binding to CD160 receptor expressed by endothelial cells

Blood, 2006-10, Vol.108 (8), p.2608-2615

2006

Volltextzugriff (PDF)

Factor Xa activates endothelial cells by a receptor cascade between EPR-1 and PAR-2

Arteriosclerosis, thrombosis, and vascular biology, 2000-11, Vol.20 (11), p.E107

2000

Volltextzugriff (PDF)

Synthesis of thrombin-inhibiting heparin mimetics without side effects

Nature (London), 1999-04, Vol.398 (6726), p.417-422

1999

Volltextzugriff (PDF)

Effect of SanOrg123781A, a synthetic hexadecasaccharide, on clot‐bound thrombin and factor Xa in vitro and in vivo

Journal of thrombosis and haemostasis, 2003-09, Vol.1 (9), p.1959-1965

2003

Volltextzugriff (PDF)

Comparative effects of two synthetic oligosaccharides on platelet activation induced by plasma from HIT patients

Journal of thrombosis and haemostasis, 2003-09, Vol.1 (9), p.2008-2013

2003

Volltextzugriff (PDF)

Apelin/APJ signaling system: a potential link between adipose tissue and endothelial angiogenic processes

The FASEB journal, 2008-12, Vol.22 (12), p.4146-4153

2008

Volltextzugriff (PDF)

Pharmacokinetics of new synthetic heparin mimetics

Thrombosis and haemostasis, 2002-06, Vol.87 (6), p.985-989

2002

Volltextzugriff (PDF)

Contribution of erythrocytes to thrombin generation in whole blood

Thrombosis and haemostasis, 1999-03, Vol.81 (3), p.400-406

1999

Volltextzugriff (PDF)

DX 9065A a novel, synthetic, selective and orally active inhibitor of factor Xa: in vitro and in vivo studies

The Journal of pharmacology and experimental therapeutics, 1996-03, Vol.276 (3), p.1030

1996

Volltextzugriff (PDF)

Comparative effects of two direct and indirect factor Xa inhibitors on free and clot-bound prothrombinase

The Journal of pharmacology and experimental therapeutics, 1997-10, Vol.283 (1), p.16

1997

Volltextzugriff (PDF)

Synthesis and Pharmacological Properties of a Close Analogue of an Antithrombotic Pentasaccharide (SR 90107A/ORG 31540)

Journal of medicinal chemistry, 1997-05, Vol.40 (11), p.1600-1607

1997

Volltextzugriff (PDF)

Biochemical and Pharmacological Properties of SANORG 34006, a Potent and Long-Acting Synthetic Pentasaccharide

Blood, 1998-06, Vol.91 (11), p.4197-4205

1998

Volltextzugriff (PDF)

SR123781A, a synthetic heparin mimetic

Thrombosis and haemostasis, 2001-05, Vol.85 (5), p.852-860

2001

Volltextzugriff (PDF)

New synthetic heparin mimetics able to inhibit thrombin and factor Xa

Bioorganic & medicinal chemistry letters, 1999-04, Vol.9 (8), p.1155-1160

1999

Volltextzugriff (PDF)

Synthesis and anti-thrombin activity of a hexasaccharide corresponding to the binding site of dermatan sulfate to heparin cofactor II

Bioorganic & medicinal chemistry letters, 1997-11, Vol.7 (22), p.2843-2846

1997

Volltextzugriff (PDF)

The structure of synthetic oligosaccharides in relation to factor IXa inhibition

Thrombosis and haemostasis, 2002-09, Vol.88 (3), p.432-435

2002

Volltextzugriff (PDF)

Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats

Thrombosis and haemostasis, 2002-02, Vol.87 (2), p.238-244

2002

Volltextzugriff (PDF)

Reversible biotinylated oligosaccharides: a new approach for a better management of anticoagulant therapy

Journal of thrombosis and haemostasis, 2008-10, Vol.6 (10), p.1697-1706

2008

Volltextzugriff (PDF)

Biochemical and Pharmacological Properties of SANORG 32701: Comparison With the `Synthetic Pentasaccharide' (SR 90107/ORG 31540) and Standard Heparin

Circulation research, 1996-09, Vol.79 (3), p.590-600

1996

Volltextzugriff (PDF)

Experimental Proof for the Structure of a Thrombin-Inhibiting Heparin Molecule

Chemistry : a European journal, 2001-02, Vol.7 (4), p.858-873

2001

Volltextzugriff (PDF)

The effect of the synthetic pentasaccharide SR 90107/ORG 31540 on thrombin generation ex vivo is uniquely due to ATIII-mediated neutralization of factor Xa

Thrombosis and haemostasis, 1995, Vol.74 (6), p.1474-1477

1995

Volltextzugriff (PDF)

Effect of SR121566A, a potent GP IIb-IIIa antagonist on platelet-mediated thrombin generation in vitro and in vivo

Thrombosis and haemostasis, 1998-02, Vol.79 (2), p.383-388

1998

Volltextzugriff (PDF)

Effect of factor Xa inhibitors on the platelet-derived microparticles procoagulant activity in vitro and in vivo in rats

Thrombosis and haemostasis, 2000-10, Vol.84 (4), p.668-674

2000

Volltextzugriff (PDF)

Effector protease receptor 1 mediates the mitogenic activity of factor Xa for vascular smooth muscle cells in vitro and in vivo

The Journal of clinical investigation, 1998-03, Vol.101 (5), p.993-1000

1998

Volltextzugriff (PDF)

1 – 25 von 359

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(306)
Mit Volltextzugriff
(295)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(203)
Life Sciences & Biomedicine
(145)
Humans
(119)
Biological And Medical Sciences
(73)
Medical Sciences
(54)
Male
(53)
Animals
(47)
Hematology
(46)
Physical Sciences
(40)
Technology
(39)
Life Sciences
(37)
Pharmacology. Drug Treatments
(34)
Female
(33)
Physics
(27)
Blood. Blood Coagulation. Reticuloendothelial System
(25)
Factor Xa Inhibitors
(22)
Middle Aged
(22)
Cardiovascular System & Cardiology
(21)
Fundamental And Applied Biological Sciences. Psychology
(21)
Peripheral Vascular Disease
(21)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effect of clopidogrel on thrombin generation in platelet-rich plasma in the rat

Soluble HLA-G1 inhibits angiogenesis through an apoptotic pathway and by direct binding to CD160 receptor expressed by endothelial cells

Factor Xa activates endothelial cells by a receptor cascade between EPR-1 and PAR-2

Synthesis of thrombin-inhibiting heparin mimetics without side effects

Effect of SanOrg123781A, a synthetic hexadecasaccharide, on clot‐bound thrombin and factor Xa in vitro and in vivo

Comparative effects of two synthetic oligosaccharides on platelet activation induced by plasma from HIT patients

Apelin/APJ signaling system: a potential link between adipose tissue and endothelial angiogenic processes

Pharmacokinetics of new synthetic heparin mimetics

Contribution of erythrocytes to thrombin generation in whole blood

DX 9065A a novel, synthetic, selective and orally active inhibitor of factor Xa: in vitro and in vivo studies

Comparative effects of two direct and indirect factor Xa inhibitors on free and clot-bound prothrombinase

Synthesis and Pharmacological Properties of a Close Analogue of an Antithrombotic Pentasaccharide (SR 90107A/ORG 31540)

Biochemical and Pharmacological Properties of SANORG 34006, a Potent and Long-Acting Synthetic Pentasaccharide

SR123781A, a synthetic heparin mimetic

New synthetic heparin mimetics able to inhibit thrombin and factor Xa

Synthesis and anti-thrombin activity of a hexasaccharide corresponding to the binding site of dermatan sulfate to heparin cofactor II

The structure of synthetic oligosaccharides in relation to factor IXa inhibition

Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats

Reversible biotinylated oligosaccharides: a new approach for a better management of anticoagulant therapy

Biochemical and Pharmacological Properties of SANORG 32701: Comparison With the `Synthetic Pentasaccharide' (SR 90107/ORG 31540) and Standard Heparin

Experimental Proof for the Structure of a Thrombin-Inhibiting Heparin Molecule

The effect of the synthetic pentasaccharide SR 90107/ORG 31540 on thrombin generation ex vivo is uniquely due to ATIII-mediated neutralization of factor Xa

Effect of SR121566A, a potent GP IIb-IIIa antagonist on platelet-mediated thrombin generation in vitro and in vivo

Effect of factor Xa inhibitors on the platelet-derived microparticles procoagulant activity in vitro and in vivo in rats

Effector protease receptor 1 mediates the mitogenic activity of factor Xa for vascular smooth muscle cells in vitro and in vivo

Suchergebnisse filtern